hydroxyurea   Click here for help

GtoPdb Ligand ID: 6822

Synonyms: Droxia® | Hydrea® | hydroxycarbamide | Siklos® | SQ-1089 | Xromi®
Approved drug PDB Ligand
hydroxyurea is an approved drug (FDA (1967), EMA (2007))
Compound class: Synthetic organic
Comment: Inhibits ribonucleoside-diphosphate reductase (RR1).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 2
Hydrogen bond donors 3
Rotatable bonds 1
Topological polar surface area 75.35
Molecular weight 76.03
XLogP -1.61
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES NC(=O)NO
Isomeric SMILES NC(=O)NO
InChI InChI=1S/CH4N2O2/c2-1(4)3-5/h5H,(H3,2,3,4)
InChI Key VSNHCAURESNICA-UHFFFAOYSA-N
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
ribonucleotide reductase catalytic subunit M1 Primary target of this compound Hs Inhibitor Inhibition 3.8 pIC50 - 1
pIC50 3.8 (IC50 1.48x10-4 M) [1]
Description: Dissolved in 1% DMSO, in vitro assay using reconstituted RRM1/RRM2 holoenzyme
ribonucleotide reductase regulatory subunit M2 Primary target of this compound Hs Inhibitor Inhibition 3.8 pIC50 - 1
pIC50 3.8 (IC50 1.48x10-4 M) [1]
Description: Dissolved in 1% DMSO, in vitro assay using reconstituted RRM1/RRM2 holoenzyme